> My guess (based upon personal experience within an entirely different industry), is that biotech management stinks at negotiations just like the technical teams I know. <
Actually Paul Goddard was a senior executive on the other side of partnership discussions when he was at Smithkline, and John Varian is a top notch executive who has handled many negotiations from the sale of Neurex, to the sale of Genset, on very good terms.
Market Data 
Markets 
AI
